Linda Henry

发表

The combination of the enhanced liver fibrosis and FIB‐4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease

Z. Goodman, M. Stepanova, Z. Younossi, 2023, Alimentary pharmacology & therapeutics.

Expediting Treatment of Trauma Patients in the Emergency Department: Rapid Trauma Evaluation (RTE).

J. Howell, M. Stepanova, Anna B. Newcomb, 2023, The Journal of emergency medicine.

Lifestyle interventions in nonalcoholic fatty liver disease

L. Gerber, Z. Younossi, S. Zelber-Sagi, 2023, Nature Reviews Gastroenterology & Hepatology.

Identification of High Risk NAFLD Patients in Endocrinology Clinics.

K. Cusi, Z. Younossi, S. Isaacs, 2023, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

How long is too long: A retrospective study evaluating the impact of the duration of noninvasive oxygenation support strategies (high flow nasal cannula & BiPAP) on mortality in invasive mechanically ventilated patients with COVID-19

M. Stepanova, M. Desai, B. Lam, 2023, PloS one.

Stigma in NAFLD and NASH: a global survey of patients and providers

V. Wong, K. Cusi, T. Kawaguchi, 2023, Journal of Hepatology.

Systematic review: patient‐reported outcomes in chronic hepatitis C ‐ the impact of liver disease and new treatment regimens

L. Henry, Z. Younossi, Z. Younossi, 2015, Alimentary pharmacology & therapeutics.

Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan

M. Mizokami, Y. Eguchi, Z. Younossi, 2018, Journal of viral hepatitis.

Sofosbuvir and ledipasvir improve patient‐reported outcomes in patients co‐infected with hepatitis C and human immunodeficiency virus

M. Stepanova, L. Henry, Z. Younossi, 2016, Journal of viral hepatitis.

The impact of chronic hepatitis C on resource utilisation and in‐patient mortality for Medicare beneficiaries between 2005 and 2010

M. Stepanova, L. Henry, Z. Younossi, 2013, Alimentary pharmacology & therapeutics.

Systematic review with meta‐analysis: non‐alcoholic steatohepatitis ‐ a case for personalised treatment based on pathogenic targets

L. Henry, Z. Younossi, A. Mishra, 2014, Alimentary pharmacology & therapeutics.

Sofosbuvir and velpatasvir with or without voxilaprevir in direct‐acting antiviral‐naïve chronic hepatitis C: patient‐reported outcomes from POLARIS 2 and 3

T. Asselah, M. Stepanova, L. Henry, 2018, Alimentary pharmacology & therapeutics.

The impact of type 2 diabetes and obesity on the long‐term outcomes of more than 85 000 liver transplant recipients in the US

S. Saab, M. Stepanova, L. Henry, 2014, Alimentary pharmacology & therapeutics.

The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019

Z. Younossi, J. Ong, James M. Paik, 2023, Hepatology communications.

The impact of viral hepatitis‐related hepatocellular carcinoma to post‐transplant outcomes

S. Saab, M. Stepanova, L. Henry, 2016, Journal of viral hepatitis.

Assessment of fatigue and its impact in chronic liver disease.

Z. Younossi, C. Bowlus, Lynn Gerber, 2024, Journal of hepatology.

Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United States

Z. Younossi, C. Venkatesan, A. Mishra, 2015, Journal of viral hepatitis.

The Transition in Terminology: From Non-alcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) to Metabolic-associated Steatotic Liver Disease (MASLD).

Z. Younossi, James M. Paik, Linda Henry, 2024, Journal of Hepatology.

Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease.

M. Stepanova, Z. Younossi, J. Ong, 2024, Journal of hepatology.

Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.

M. Stepanova, A. Duseja, Z. Younossi, 2023, Journal of hepatology.

The burden of metabolic dysfunction-associated steatotic liver disease and viral hepatitis in Saudi Arabia.

Z. Younossi, K. Bzeizi, W. Al-Hamoudi, 2024, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

Nonalcoholic fatty liver disease mortality may not be decreasing: A need for careful interpretation of GBD 2019 estimates of liver deaths.

Z. Younossi, James M. Paik, Linda Henry, 2023, Cell metabolism.